CHAPTER II: Strategies for Adopting the Guidelines for Prescribing Opioids for Chronic Pain 2016 HCR 113 REQUEST: Evaluate the responsible use of opioid medications, including the adoption of for Prescribing Opioids for Chronic Pain (March 2016 from CDC).” “Guidelines RECOMMENDATIONS: 2-1. Prescriber licensing boards should adopt the CDC guidelines for primary care physicians which focus on the first twelve weeks of therapy. 2-2. Prescriber licensing boards should adopt and adapt, to the extent possible, language from La. Admin. C. 46:6915 et seq. that provides guidance on Medications Used in the Treatment of Non-Cancer Related Chronic or Intractable Pain. 2-3. A roster of addiction medicine and pain management specialists should be developed, and consultation with these professionals should be encouraged for prescribers that have clients enrolled in long-term opioid therapy; this roster should be advertised to the prescriber community. 2-4. Prevention education is encouraged to inform the public about addiction, the risks of taking opioid medications, and viable alternatives for the treatment of pain. The focus and implementation methods of these educational strategies should include: Medical students should be educated by the professional medical programs in which they are enrolled Licensing boards should educate prescribers. The public should be educated through a series of public service announcements.
CHAPTER II: Strategies for Adopting the Guidelines for Prescribing Opioids for Chronic Pain 2016 HCR 113 REQUEST: Evaluate the responsible use of opioid medications, including the adoption of “Guidelines for Prescribing Opioids for Chronic Pain (March 2016 from CDC).” RECOMMENDATIONS: 2-1. Prescriber licensing boards should adopt the CDC guidelines for primary care physicians which focus on the first twelve weeks of therapy. 2-2. Prescriber licensing boards should adopt and adapt, to the extent possible, language from La. Admin. C. 46:6915 et seq. that provides guidance on Medications Used in the Treatment of Non-Cancer Related Chronic or Intractable Pain. 2-3. A roster of addiction medicine and pain management specialists should be developed, and consultation with these professionals should be encouraged for prescribers that have clients enrolled in long-term opioid therapy; this roster should be advertised to the prescriber community. 2-4. Prevention education is encouraged to inform the public about addiction, the risks of taking opioid medications, and viable alternatives for the treatment of pain. The focus and implementation methods of these educational strategies should include: Medical students should be educated by the professional medical programs in which they are enrolled Licensing boards should educate prescribers. The public should be educated through a series of public service announcements.